These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21818089)

  • 41. RNAi knockdown of HdmX or Hdm2 leads to new insights into p53 signaling.
    Berberich SJ
    Cell Cycle; 2010 Sep; 9(18):3640-1. PubMed ID: 20855947
    [No Abstract]   [Full Text] [Related]  

  • 42. Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.
    Zhou X; Hao Q; Liao J; Zhang Q; Lu H
    Oncogene; 2013 Jan; 32(3):388-96. PubMed ID: 22391559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
    Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
    Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of nucleolar signalling to p53 through NEDDylation of L11.
    Sundqvist A; Liu G; Mirsaliotis A; Xirodimas DP
    EMBO Rep; 2009 Oct; 10(10):1132-9. PubMed ID: 19713960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MDMX regulation of p53 response to ribosomal stress.
    Gilkes DM; Chen L; Chen J
    EMBO J; 2006 Nov; 25(23):5614-25. PubMed ID: 17110929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.
    Kamio T; Gu BW; Olson TS; Zhang Y; Mason PJ; Bessler M
    PLoS One; 2016; 11(4):e0152263. PubMed ID: 27042854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator.
    Xiong X; Zhao Y; He H; Sun Y
    Oncogene; 2011 Apr; 30(15):1798-811. PubMed ID: 21170087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.
    Sun XX; Wang YG; Xirodimas DP; Dai MS
    J Biol Chem; 2010 Aug; 285(33):25812-21. PubMed ID: 20554519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting protein interactions of p53 for therapeutic intervention: success in a frustrated landscape.
    Blundell TL; Bolanos-Garcia VM
    Cell Cycle; 2009 Nov; 8(22):3631-2. PubMed ID: 19875920
    [No Abstract]   [Full Text] [Related]  

  • 50. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ribosomal protein S3: A multi-functional protein that interacts with both p53 and MDM2 through its KH domain.
    Yadavilli S; Mayo LD; Higgins M; Lain S; Hegde V; Deutsch WA
    DNA Repair (Amst); 2009 Oct; 8(10):1215-24. PubMed ID: 19656744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.
    Goudarzi KM; Nistér M; Lindström MS
    Cancer Biol Ther; 2014; 15(11):1499-514. PubMed ID: 25482947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins.
    Lee MH; Lozano G
    Semin Cancer Biol; 2006 Jun; 16(3):225-34. PubMed ID: 16697215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heavy ion radiation-induced DNA damage mediates apoptosis via the Rpl27a-Rpl5-MDM2-p53/E2F1 signaling pathway in mouse spermatogonia.
    Li H; Zhang H; Huang G; Dou Z; Xie Y; Si J; Di C
    Ecotoxicol Environ Saf; 2020 Sep; 201():110831. PubMed ID: 32535367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2-P53 pathway.
    Zhu Y; Ren C; Jiang D; Yang L; Chen Y; Li F; Wang B; Zhang Y
    Cancer Sci; 2021 May; 112(5):1811-1821. PubMed ID: 33675124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The p53 mutation "gradient effect" and its clinical implications.
    Zambetti GP
    J Cell Physiol; 2007 Nov; 213(2):370-3. PubMed ID: 17671971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
    Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
    Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. UNC119 is a binding partner of tumor suppressor Ras-association domain family 6 and induces apoptosis and cell cycle arrest by MDM2 and p53.
    Iwasa H; Sarkar A; Shimizu T; Sawada T; Hossain S; Xu X; Maruyama J; Arimoto-Matsuzaki K; Withanage K; Nakagawa K; Kurihara H; Kuroyanagi H; Hata Y
    Cancer Sci; 2018 Sep; 109(9):2767-2780. PubMed ID: 29931788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction.
    Sun XX; Dai MS; Lu H
    J Biol Chem; 2007 Mar; 282(11):8052-9. PubMed ID: 17242401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.